Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis

NCT01018862 is registered in ClinicalTrials.gov with Meda Pharmaceuticals as lead sponsor.

NCT NCT01018862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01018862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Lead sponsor
Meda Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2009
Completion date
April 30, 2011
Enrollment
489 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

perennial allergic rhinitis